New Liferay Study Finds 54% of Companies Are Running AI Agents, Yet Only 25% Measure Their Impact

Summary

Liferay study finds that 54% of companies use or pilot AI agents, but only 25% measure their impact, indicating a gap in governance and training practices. This is a non-biotech corporate research finding with no relevance to pharmaceutical development.